Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bococizumab in Statin Intolerant Subjects with Dyslipidemia
NCT02135029Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2014
- Primary completion
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of bococizumab in hyperlipidemia, sponsored by Pfizer. Started Jun 2014; status: completed.
02
Drugs
bococizumab
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02135029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135029.